Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbCellera Biologics

3.41
-0.0600-1.73%
Post-market: 3.440.0300+0.88%19:59 EDT
Volume:8.76M
Turnover:29.47M
Market Cap:1.02B
PE:-6.00
High:3.55
Open:3.50
Low:3.24
Close:3.47
Loading ...
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 08, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 22, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 19, 2022

Major Issues Report

8-K - Current report
Jul 06, 2022

Major Issues Report

8-K - Current report
Jun 30, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals